Invesco V.I. Health Care Fund is a registered fund series of AIM Variable Insurance Funds (Invesco Variable Insurance Funds) (series S000000193). Net assets $148.4M as of 2026-03-31.
Showing 15 of 82 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly and Co. | — | $13.6M | 914.11% |
| Johnson & Johnson | — | $8.6M | 581.41% |
| AstraZeneca PLC | — | $6.5M | 436.21% |
| Gilead Sciences, Inc. | — | $6.1M | 411.72% |
| AbbVie Inc. | — | $5.5M | 372.06% |
| Cencora, Inc. | — | $5.4M | 364.93% |
| McKesson Corp. | — | $5.4M | 360.72% |
| argenx SE | — | $5.0M | 339.09% |
| Invesco Private Prime Fund | — | $4.3M | 288.54% |
| Invesco Treasury Portfolio | — | $3.7M | 247.97% |
| Merck & Co., Inc. | — | $3.4M | 226.65% |
| Welltower Inc. | — | $3.1M | 208.75% |
| HCA Healthcare, Inc. | — | $3.0M | 205.08% |
| Vertex Pharmaceuticals Inc. | — | $3.0M | 199.26% |
| Royalty Pharma PLC | — | $2.8M | 185.32% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $148.4M |
| 2025-12-31 | $168.3M |
| 2025-09-30 | $160.0M |
| 2025-06-30 | $158.5M |
| 2025-03-31 | $164.8M |
| 2024-12-31 | $164.7M |
| 2024-09-30 | $189.8M |
| 2024-06-30 | $188.4M |